Home
DRAXXIN and IPC
Package and Dosing
Pharmacology
Efficacy
Safety
News
Technical Downloads
DRAXXIN
®
(tulathromycin) Injectable Solution is a unique, novel treatment that delivers:
The one-dose cure for complex swine respiratory disease (SRD).
The broadest FDA-approved spectrum, and is indicated to treat the bacteria causing respiratory disease in growing and finishing swine
Actinobacillus pleuropneumoniae
Pasteurella multocida
Bordetella bronchiseptica
Haemophilus parasuis
Mycoplasma hyopneumoniae
For the Control of swine respiratory disease (SRD) associated with
Actinobacillus pleuropneumoniae, Pasteurella multocida
and
Mycoplasma hyopneumoniae
in groups of pigs where SRD has been diagnosed.
Excellent clinical efficacy
Exceptional pharmacokinetics in swine:
Rapid release from injection site and absorption into tissue
Extensive distribution
Slow elimination and excretion
High, prolonged lung tissue concentrations
Just one dose and DRAXXIN does the rest
Single dose = complete treatment
Provides extended therapy and demonstrated efficacy
Guarantees instant compliance, peace of mind
Minimizes labor and handling stress on sick pigs
Reduces multiple injections and the risk of broken needles
Aligned with prudent use of antibiotics and Individual Pig Care®
DRAXXIN should not be used in animals known to be hypersensitive to the product. The pre-slaughter withdrawal time for DRAXXIN in swine is five days.
References
Copyright © 2010 Pfizer Inc. All rights reserved.
Back to top
|
Site Map
|
Privacy & Use
|
Help
|
Contact Us
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.